Company news
Insmed Incorporated (NASDAQ:INSM) news
Insmed Incorporated news releases on 6ix. Latest, Aug 3, 2023: Insmed Reports Second-Quarter 2023 Financial Results and Provides Business Update
Press releases — page 3
Insmed Reports Second-Quarter 2023 Financial Results and Provides Business Update
August 2, 2023
Insmed to Host Second-Quarter 2023 Financial Results Conference Call on Thursday, August 3, 2023
July 19, 2023
Insmed To Present at the Goldman Sachs 44th Annual Global Healthcare Conference
June 6, 2023
Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference
May 21, 2023
Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, "The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More"
May 7, 2023
Insmed Reports First Quarter 2023 Financial Results and Provides Business Update
May 3, 2023
Insmed to Host Investor and Analyst Event on May 8, 2023
April 23, 2023
Insmed to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 4, 2023
April 19, 2023
Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis
March 30, 2023
Insmed to Present New Clinical, Pre-Clinical, and Real-World Data in Serious and Rare Lung Diseases at the American Thoracic Society 2023 International Conference
March 23, 2023
Insmed To Present at Two March Conferences
February 28, 2023
Insmed Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
February 22, 2023
Insmed to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, February 23, 2023
February 8, 2023
Insmed To Present at the SVB Securities Global Biopharma Conference
February 6, 2023
Insmed Provides Business Updates and Near-Term Strategic Outlook at 41st Annual J.P. Morgan Healthcare Conference
January 5, 2023
Insmed To Present at the 41st Annual J.P. Morgan Healthcare Conference
January 2, 2023
Insmed To Present at the Nasdaq 47th Investor Conference
November 29, 2022
Insmed To Present at Three November Conferences
October 31, 2022
Insmed Reports Third Quarter 2022 Financial Results and Provides Business Update
October 26, 2022
Insmed Ranks No. 1 on Science's 2022 Top Biopharma Employers List
October 26, 2022
Insmed Announces Strategic Financings Totaling $775 Million
October 18, 2022
Insmed to Host Third Quarter 2022 Financial Results Conference Call on Thursday, October 27, 2022
October 12, 2022
Insmed Holds Inaugural Global Day of Good - A Company-Wide Day of Service
October 5, 2022
Insmed To Present at Two September Conferences
September 5, 2022
Insmed Reports Second Quarter 2022 Financial Results and Provides Business Update
August 3, 2022
Insmed to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022
July 20, 2022
Insmed Names Drayton Wise Chief Commercial Officer
May 22, 2022
Insmed To Present at the H.C. Wainwright Annual Global Life Sciences Conference
May 16, 2022
Insmed Presents New Data Across Three Pillars at American Thoracic Society 2022 International Conference
May 16, 2022
Insmed Reports First Quarter 2022 Financial Results and Provides Business Update
May 4, 2022
Insmed to Host First Quarter 2022 Financial Results Conference Call on Thursday, May 5, 2022
April 20, 2022
Insmed to Showcase New Data Across Three Pillars at the American Thoracic Society 2022 International Conference
March 27, 2022
Insmed To Present at the Cowen 42nd Annual Health Care Conference
March 2, 2022
Insmed Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business and Pipeline Update
February 16, 2022
Insmed To Present at the SVB Leerink Virtual 11th Annual Global Healthcare Conference
February 9, 2022
Insmed to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Provide a Business and Pipeline Update on Thursday, February 17, 2022
January 26, 2022
Insmed To Present at the 40th Annual J.P. Morgan Healthcare Conference
January 3, 2022
Insmed To Participate in Three November Conferences
November 2, 2021
Insmed Reports Third Quarter 2021 Financial Results and Provides Business Update
October 27, 2021
Insmed Ranks No. 1 on Science's 2021 Top Biopharma Employers List
October 27, 2021
Insmed to Host Third Quarter 2021 Financial Results Conference Call on Thursday, October 28, 2021
October 13, 2021
Insmed To Participate in Five September Conferences
August 31, 2021
Insmed Reports Second Quarter 2021 Financial Results and Provides Business Update
August 4, 2021
Insmed to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021
July 26, 2021
Insmed To Present at Two June Conferences
May 24, 2021
Insmed Presents Broad Range of Data Across Its Three Programs at the American Thoracic Society 2021 International Conference
May 18, 2021
Insmed Announces Closing of Public Offerings of Common Stock and Convertible Senior Notes and Full Exercise of Underwriters' Options to Purchase Additional Shares and Notes
May 12, 2021
Insmed Announces Pricing of Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028
May 10, 2021
Insmed Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028
May 9, 2021
Insmed Reports First Quarter 2021 Financial Results and Provides Business Update
May 5, 2021